eli lilly retatrutide trials Phase 3 obesity trial results 2026 Eli Lilly's retatrutide cuts weight

Hims & Hers offers life-changing weight-loss medications

Medical experts warn that these products can be dangerous for several reasons: Lack of FDA approval Retatrutide has not been approved for any medical use and has not undergone a full regulatory safety review

The crucial question remains whether these benefits are sustainable over time and if the medication is safe for prolonged use

While this may seem daunting initially, the health benefits of sustained weight loss often outweigh the commitment required

If you purchase through these links, a commission may be earned at no additional cost to you

Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks